Annotated Medicine and Device Lists

Ribavirin

Injection for intravenous administration 800 mg in 10-ml phosphate buffer solution Injection for intravenous administration 1 g in 10-ml phosphate buffer solution Solid oral dosage form 200 mg Solid oral dosage form 400 mg Solid oral dosage form 600 mg Tablet 400 mg

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.4.2.3 Other antivirals for hepatitis C	Others observations: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines.
WHO Model List of Essential Medicines (2021)	6.4.3. Other antivirals	Others observations: For the treatment of viral haemorrhagic fevers.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.4.2.3 Other antivirals for hepatitis C	Others observations: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines.
WHO Model List of Essential Medicines (2021)	6.4.3. Other antivirals	Others observations: For the treatment of viral haemorrhagic fevers.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.4.2.3 Other antivirals for hepatitis C	Others observations: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines.
WHO Model List of Essential Medicines (2021)	6.4.3. Other antivirals	Others observations: For the treatment of viral haemorrhagic only.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.4.2.3 Other antivirals for hepatitis C	Others observations: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines
WHO Model List of Essential Medicines (2021)	6.4.3. Other antivirals	Others observations: For the treatment of viral haemorrhagic fevers.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	6.4.3. Other antivirals	Others observations: For the treatment of viral haemorrhagic fevers.
WHO Model List of Essential Medicines (2021)	6.4.4.2.3 Other antivirals for hepatitis C	Others observations: For the treatment of hepatitis C, in combination with direct acting anti-viral medicines.

This medicine is present in:

List	Section	Observation
Cuba	6.4 Antivirales	No observations

Information Resources: Ribavirin

No information available